Agenus
AGEN
#8329
Rank
A$0.45 B
Marketcap
A$10.07
Share price
-0.56%
Change (1 day)
72.04%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): A$0.22 Billion

According to Agenus 's latest financial reports the company's current earnings are A$0.13 Billion. In 2025 the company made an earning of A$74.13 Million, an increase over its 2024 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.22 B201.81%
2025 A$74.13 M-145.52%
2024 -A$0.17 Billion-28.13%
2023 -A$0.23 Billion-5.5%
2022 -A$0.24 Billion-556.26%
2021 A$52.55 M-130.37%
2020 -A$0.18 Billion73.75%
2019 -A$99.59 Million-48.74%
2018 -A$0.2 Billion34.32%
2017 -A$0.15 Billion-7.16%
2016 -A$0.16 Billion26.55%
2015 -A$0.13 Billion110.24%
2014 -A$58.56 Million49.12%
2013 -A$39.27 Million
2011 -A$27.12 Million-12.25%
2010 -A$30.9 Million-21.41%
2009 -A$39.32 Million-26.86%
2008 -A$53.76 Million13.72%
2007 -A$47.28 Million-33.4%
2006 -A$70.98 Million-31.84%
2005 -A$0.11 Billion9.74%
2004 -A$94.89 Million-0.8%
2003 -A$95.66 Million17.37%
2002 -A$81.51 Million37.83%
2001 -A$59.14 Million55.99%
2000 -A$37.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.22 B 17,251.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.92 B 4,991.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.91 B 7,785.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$11.20 B 5,123.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-A$0.47 Billion-315.73%๐Ÿ‡บ๐Ÿ‡ธ USA